This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: j.jacc.2006.05.047v1 48/6/1183    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wattanakit, K. Articles by Folsom, A. R. Search for Related Content PubMed PubMed Citation Articles by Wattanakit, K. Articles by Folsom, A. R.

CLINICAL RESEARCH

Cardiovascular Risk Among Adults With Chronic Kidney Disease, With or Without Prior Myocardial Infarction

Keattiyoat Wattanakit, MD, MPH^_*, Josef Coresh, MD, PhD, Paul Muntner, PhD, Jane Marsh, PhD and Aaron R. Folsom, MD, MPH^_*,_*

^_* Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, Minnesota
Welch Center for Prevention, Epidemiology, and Clinical Research and the Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
Tulane University School of Public Health and Tropical Medicine, New Orleans, Louisiana

Manuscript received December 14, 2005; revised manuscript received May 1, 2006, accepted May 16, 2006.

^_* Reprint requests and correspondence: Dr. Aaron R. Folsom, Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Suite 300, 1300 South Second Street, Minneapolis, Minnesota 55454-1015. (Email: folsom{at}epi.umn.edu).

OBJECTIVES: This study sought to determine whether chronic kidney disease (CKD) should be considered a coronary heart disease (CHD) risk equivalent for cholesterol treatment.

BACKGROUND: It is unclear whether patients with CKD have a risk of CHD events or cardiovascular disease (CVD) mortality equivalent to patients with a prior myocardial infarction (MI).

METHODS: Using data from the ARIC (Atherosclerosis Risk in Communities) study, we categorized nondiabetic participants based on their average level of kidney function (estimated glomerular filtration rate 60 or 30 to 59 ml/min/1.73 m², which defines stage 3 CKD) and on prior MI (yes or no). Rates and relative risks (RR) of CHD (MI or fatal CHD) events (n = 653) and CVD mortality (n = 209) that occurred over 10 years were compared across these populations.

RESULTS: Among 12,243 middle-age participants, 271 had stage 3 CKD. After adjustment for age, gender, race, and center, CHD incidence and CVD mortality rates per 1,000 person-years by presence of CKD and MI were 4.1 and 1.0 in the presence of neither condition, 8.0 and 3.4 in CKD only, 18.8 and 7.0 in MI only, and 30.8 and 18.0 in CKD and MI. After further adjustment for CVD risk factors, RR of CHD and CVD mortality were statistically significantly lower in subjects with CKD and no prior MI (RR = 0.44 [95% confidence interval (CI) 0.28 to 0.72] for CHD and RR = 0.46 [95% CI 0.24 to 0.90] for CVD mortality) than for subjects with no CKD and a prior MI.

CONCLUSIONS: Stage 3 CKD confers CHD risk that is lower and not equivalent to a prior MI in this middle-aged, general, nondiabetic population.

Abbreviations and Acronyms   ARIC = Atherosclerosis Risk in Communities study   CHD = coronary heart disease   CI = confidence interval   CKD = chronic kidney disease   CVD = cardiovascular disease   eGFR = estimated glomerular filtration rate   IMT = intima-media thickness   LDL = low-density lipoprotein   MI = myocardial infarction   NCEP ATP-III = National Cholesterol Education Program Adult Treatment Panel-III   RR = relative risk

This article has been cited by other articles:

				B.C. Astor, S. Yi, L. Hiremath, T. Corbin, V. Pogue, B. Wilkening, G. Peterson, J. Lewis, J.P. Lash, F. Van Lente, et al. N-Terminal Prohormone Brain Natriuretic Peptide as a Predictor of Cardiovascular Disease and Mortality in Blacks With Hypertensive Kidney Disease: The African American Study of Kidney Disease and Hypertension (AASK) Circulation, April 1, 2008; 117(13): 1685 - 1692. [Abstract] [Full Text] [PDF]

				R. P. Donahue, S. Stranges, K. Rejman, L. B. Rafalson, J. Dmochowski, and M. Trevisan Elevated Cystatin C Concentration and Progression to Pre-Diabetes: The Western New York Study Diabetes Care, July 1, 2007; 30(7): 1724 - 1729. [Abstract] [Full Text] [PDF]

				C.-C. Szeto, K.-M. Chow, K.-S. Woo, P. Chook, B. Ching-Ha Kwan, C.-B. Leung, and P. Kam-Tao Li Carotid Intima Media Thickness Predicts Cardiovascular Diseases in Chinese Predialysis Patients with Chronic Kidney Disease J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1966 - 1972. [Abstract] [Full Text] [PDF]

				R. C. Blantz Handing Out Grades for Care in Chronic Kidney Disease: Nephrologists versus Non-Nephrologists Clin. J. Am. Soc. Nephrol., March 1, 2007; 2(2): 193 - 195. [Full Text] [PDF]